More recently, the one-cell stage injection has also been used to study phenotype restoration in a model of Wolfram syndrome, a rare neurodegenerative disease caused by mutations in the Wolframin (WFS1) gene. The gene discussed is WFS1; the disease is Wolfram syndrome.